Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

RIBOFLAVIN IN PSORIASIS

RIBOFLAVIN IN PSORIASIS Abstract It is with apprehension that one reports any new form of treatment for psoriasis. However, the results with a new form of riboflavin have been so encouraging in a limited number of cases that this preliminary report is issued. Relatively recent discoveries on the mode of action of riboflavin have suggested its use in some of the scaly skin diseases of man. B2 deficiency in monkeys sometimes results in the appearance of a scaly dermatitis,1 and in man eruptions of this type are also associated with the B2 deficiency state, leading one to wonder whether any of the common maculo-or papulo-squamous eruptions are related to abnormalities of riboflavin metabolism. Riboflavin is required in the oxidative process in metabolism,2 and its administration probably results in improved skin respiration.3 Most important from the point of view of this study is the necessity of this vitamin References 1. Prepared by S. F. Durst & Company and now marketed as HYRYE. 2. Mann, G. V.: J. Nutrition 47:225, 1952. 3. Andrae, W. A.: Fed. Proc. 5:3, 1946. 4. Rosel, S. I.: Vestnik oftal. 30:26-33, 1951. 5. Forker, B. R., and Morgan, A. F.: J. Biol. Chem. 209:303-311, 1954. 6. Yaki, K.: J. Biochem. 41( (6) ) 757-762, 1954. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png A.M.A. Archives of Dermatology American Medical Association

RIBOFLAVIN IN PSORIASIS

LUSCOMBE, HERBERT A.
A.M.A. Archives of Dermatology , Volume 74 (5) – Nov 1, 1956
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/riboflavin-in-psoriasis-QlbJPasFID

References (3)

Publisher
American Medical Association
Copyright
Copyright © 1956 American Medical Association. All Rights Reserved.
ISSN
0096-5359
DOI
10.1001/archderm.1956.01550110092019
Publisher site
See Article on Publisher Site

Abstract

Abstract It is with apprehension that one reports any new form of treatment for psoriasis. However, the results with a new form of riboflavin have been so encouraging in a limited number of cases that this preliminary report is issued. Relatively recent discoveries on the mode of action of riboflavin have suggested its use in some of the scaly skin diseases of man. B2 deficiency in monkeys sometimes results in the appearance of a scaly dermatitis,1 and in man eruptions of this type are also associated with the B2 deficiency state, leading one to wonder whether any of the common maculo-or papulo-squamous eruptions are related to abnormalities of riboflavin metabolism. Riboflavin is required in the oxidative process in metabolism,2 and its administration probably results in improved skin respiration.3 Most important from the point of view of this study is the necessity of this vitamin References 1. Prepared by S. F. Durst & Company and now marketed as HYRYE. 2. Mann, G. V.: J. Nutrition 47:225, 1952. 3. Andrae, W. A.: Fed. Proc. 5:3, 1946. 4. Rosel, S. I.: Vestnik oftal. 30:26-33, 1951. 5. Forker, B. R., and Morgan, A. F.: J. Biol. Chem. 209:303-311, 1954. 6. Yaki, K.: J. Biochem. 41( (6) ) 757-762, 1954.

Journal

A.M.A. Archives of Dermatology – American Medical Association

Published: Nov 1, 1956

There are no references for this article.